English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carboxylic acid/cannabis
The link is saved to the clipboard
9 results
Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same
Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a 35 U.S.C. .sctn.371 national stage entry of PCT/EP2012/004107, which has an international filing date of Oct. 1, 2012, and claims priority to German Patent Application No. 102011114528.5, filed on Sep. 29, 2011, contents of each of
1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists
Only registered users can translate articles
Log In/Sign up
The subject of the present invention is compounds which are antagonists of the cannabinoid CB.sub.2 receptors, their preparation, pharmaceutical compositions containing them. The compounds of the invention are tricyclic derivatives of 1-benzylpyrazole-3-carboxylic acid.
Patent applications EP-A-576
Cannabinoid and terpene-infused topical cream
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention is generally directed to novel compositions and methods for treatment of dermatologic conditions. More particularly, a composition comprising Terpene and cannabidiol (CBD) or derivatives thereof for treating inflammatory skin disorders. Further, the
Oral detection test for cannabinoid use
Only registered users can translate articles
Log In/Sign up
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The field of the present invention relates to the detection of controlled substances, and in particular to the detection of a metabolite of
Oral detection test for cannabinoid use
Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCE TO RELATED APPLICATIONS
Not Applicable.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The field of the present invention relates to the detection of controlled substances, and in particular to the
Oral detection test for cannabinoid use
Only registered users can translate articles
Log In/Sign up
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The field of the present invention relates to the detection of controlled substances, and in particular to the detection of a metabolite of
Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE TO RELATED APPLICATION
This application is a national stage of PCT/EP01/11967 filed Oct. 16, 2001 and based upon DE 100 51 427.8 filed Oct. 17, 2000 under the International Convention.
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a process for
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to crystalline forms of (1aS,5aS)-2-(4-oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclop- ropa[a]pentalene-4-carboxylic acid ((S)-1-hydroxymethyl-2,2-dimethyl-propyl)-amide (Compound 1) and pharmaceutical compositions thereof that
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to crystalline forms of (1aS,5aS)-2-(4-oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclop- ropa[a]pentalene-4-carboxylic acid ((S)-1-hydroxymethyl-2,2-dimethyl-propyl)-amide (Compound 1) and pharmaceutical compositions thereof that
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
